Treatment of toxoplasmic encephalitis with intravenous clindamycin
- 1 November 1988
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Internal Medicine
- Vol. 148 (11), 2477-2482
- https://doi.org/10.1001/archinte.148.11.2477
Abstract
Research from JAMA Internal Medicine — Treatment of Toxoplasmic Encephalitis With Intravenous ClindamycinThis publication has 14 references indexed in Scilit:
- Potent Effect of Trimetrexate, a Lipid-Soluble Antifolate, on Toxoplasma gondiiThe Journal of Infectious Diseases, 1987
- Clindamycin in a murine model of toxoplasmic encephalitisAntimicrobial Agents and Chemotherapy, 1987
- In vivo synergism of roxithromycin (RU 965) and interferon against Toxoplasma gondiiAntimicrobial Agents and Chemotherapy, 1987
- Cerebral toxoplasmosis complicating the acquired immune deficiency syndrome: Clinical and neuropathological findings in 27 patientsAnnals of Neurology, 1986
- In vivo recombinant interleukin 2 administration enhances survival against a lethal challenge with Toxoplasma gondii.The Journal of Immunology, 1985
- ACQUIRED IMMUNODEFICIENCY SYNDROME - CLINICOPATHOLOGIC STUDY OF 56 AUTOPSIES1985
- Toxoplasmic encephalitis in patients with acquired immune deficiency syndromeJAMA, 1984
- Acquired immunodeficiency syndrome: cerebral computed tomographic manifestations.Radiology, 1983
- Neurological complications of acquired immune deficiency syndrome: Analysis of 50 patientsAnnals of Neurology, 1983
- Toxoplasma gondii infection of the central nervous systemHuman Pathology, 1981